Cargando…

The Genetics of Alzheimer’s Disease in the Chinese Population

Alzheimer’s disease (AD) is a neurodegenerative disease characterized by progressive cognitive dysfunction and behavioral impairment. In China, the number of AD patients is growing rapidly, which poses a considerable burden on society and families. In recent years, through the advancement of genome-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gan, Chen-Ling, Zhang, Tao, Lee, Tae Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178026/ https://www.ncbi.nlm.nih.gov/pubmed/32235595 http://dx.doi.org/10.3390/ijms21072381

Ejemplares similares

Phosphorylation Signaling in APP Processing in Alzheimer’s Disease
por: Zhang, Tao, et al.
Publicado: (2019)

Genetic and polygenic risk score analysis for Alzheimer's disease in the Chinese population
por: Zhou, Xiaopu, et al.
Publicado: (2020)

Genetics of Alzheimer’s Disease in the African American Population
por: Logue, Mark W., et al.
Publicado: (2023)

Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population
por: Xiao, Qianyi, et al.
Publicado: (2015)

The genetics of Alzheimer’s disease
por: Bagyinszky, Eva, et al.
Publicado: (2014)

Genetics of Alzheimer’s Disease
por: Guerreiro, Rita, et al.
Publicado: (2014)

The Genetic Variation of SORCS1 Is Associated with Late-Onset Alzheimer’s Disease in Chinese Han Population
por: Xu, Wei, et al.
Publicado: (2013)

Analysis of Genetic Association Between ABCA7 Polymorphism and Alzheimer’s Disease Risk in the Southern Chinese Population
por: Wang, Lijun, et al.
Publicado: (2022)

Genetics of Alzheimer's Disease
por: Ridge, Perry G., et al.
Publicado: (2013)

The Genetics of Alzheimer's Disease
por: Barber, Robert C.
Publicado: (2012)

Genetics of Alzheimer's Disease
por: Kim, Jong Hun
Publicado: (2018)

Programmed Cell Death Protein 1 Blockade Reduces Glycogen Synthase Kinase 3β Activity and Tau Hyperphosphorylation in Alzheimer’s Disease Mouse Models
por: Zou, Yulian, et al.
Publicado: (2021)

Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis
por: Zhou, Xiaopu, et al.
Publicado: (2018)

Genetic Variants in GAPDH Confer Susceptibility to Sporadic Parkinson’s Disease in a Chinese Han Population
por: Liu, Ling, et al.
Publicado: (2015)

SORL1 gene, plasma biomarkers, and the risk of Alzheimer’s disease for the Han Chinese population in Taiwan
por: Chou, Cheng-Ta, et al.
Publicado: (2016)

Clinical Genetics of Alzheimer's Disease
por: Zou, Zhangyu, et al.
Publicado: (2014)

Genetics of Alzheimer's disease: recent advances
por: Avramopoulos, Dimitrios
Publicado: (2009)

Genetic Dissection of Alzheimer’s Disease Using Drosophila Models
por: Jeon, Youngjae, et al.
Publicado: (2020)

Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
por: Wang, Long, et al.
Publicado: (2023)

Network Medicine for Alzheimer’s Disease and Traditional Chinese Medicine
por: Jarrell, Juliet T., et al.
Publicado: (2018)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
por: Zhang, Nan, et al.
Publicado: (2018)

Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease
por: Sun, Zhi-Kun, et al.
Publicado: (2013)

Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis
por: Liu, Mengying, et al.
Publicado: (2014)

Mendelian randomization analyses of smoking and Alzheimer’s disease in Chinese and Japanese populations
por: Zhu, Yuan, et al.
Publicado: (2023)

Age and sex differences in the association between APOE genotype and Alzheimer’s disease in a Taiwan Chinese population
por: Huang, Ling-Chun, et al.
Publicado: (2023)

Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
por: Ibanez, Laura, et al.
Publicado: (2021)

Genetic Insights into the Impact of Complement in Alzheimer’s Disease
por: Torvell, Megan, et al.
Publicado: (2021)

Alzheimer’s Disease: An Updated Overview of Its Genetics
por: Andrade-Guerrero, Jesús, et al.
Publicado: (2023)

A Comprehensive Analysis of the CaMK2A Gene and Susceptibility to Alzheimer’s Disease in the Han Chinese Population
por: Fang, Xinyu, et al.
Publicado: (2019)

Association of Genetic Loci with Blood Lipids in the Chinese Population
por: Zhang, Zhou, et al.
Publicado: (2011)

Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's Disease
por: Sulistio, Yanuar Alan, et al.
Publicado: (2015)

Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease
por: Zhang, Tao, et al.
Publicado: (2022)

Recent Progress in Alzheimer’s Disease Research, Part 2: Genetics and Epidemiology
por: Robinson, Morgan, et al.
Publicado: (2017)

Are Parkinson’s Disease Patients the Ideal Preclinical Population for Alzheimer’s Disease Therapeutics?
por: Tropea, Thomas F., et al.
Publicado: (2021)

Melatonin ameliorates tau-related pathology via the miR-504-3p and CDK5 axis in Alzheimer’s disease
por: Chen, Dongmei, et al.
Publicado: (2022)

Genetics of Alzheimer disease in the pre- and post-GWAS era
por: Ertekin-Taner, Nilüfer
Publicado: (2010)

The genetic landscape of Alzheimer disease: clinical implications and perspectives
por: Van Cauwenberghe, Caroline, et al.
Publicado: (2016)

Genetics ignite focus on microglial inflammation in Alzheimer’s disease
por: Malik, Manasi, et al.
Publicado: (2015)

Genetic Heterogeneity of Alzheimer’s Disease: Embracing Research Partnerships
por: Nacmias, Benedetta, et al.
Publicado: (2018)

Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease
por: Newcombe, Estella A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0phkttdbj0g6mpm0dkjn9cjbiv